Literature DB >> 17909706

Triple antithrombotic therapy with aspirin, clopidogrel and warfarin--a persisting dilemma.

M Zimarino1, G Renda, R De Caterina.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17909706     DOI： 10.1007/s11739-007-0054-6

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN： 1828-0447            Impact factor:   3.397


× No keyword cloud information.
  8 in total

1.  ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention-Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention).

Authors:  Sidney C Smith; Ted E Feldman; John W Hirshfeld; Alice K Jacobs; Morton J Kern; Spencer B King; Douglass A Morrison; William W O'neill; Hartzell V Schaff; Patrick L Whitlow; David O Williams; Elliott M Antman; Sidney C Smith; Cynthia D Adams; Jeffrey L Anderson; David P Faxon; Valentin Fuster; Jonathan L Halperin; Loren F Hiratzka; Sharon Ann Hunt; Alice K Jacobs; Rick Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel
Journal:  J Am Coll Cardiol       Date:  2006-01-03       Impact factor: 24.094

2.  Anticoagulants in heart disease: current status and perspectives.

Authors:  Raffaele De Caterina; Steen Husted; Lars Wallentin; Giancarlo Agnelli; Fedor Bachmann; Colin Baigent; Jørgen Jespersen; Steen Dalby Kristensen; Gilles Montalescot; Agneta Siegbahn; Freek W A Verheugt; Jeffrey Weitz
Journal:  Eur Heart J       Date:  2007-04-10       Impact factor: 29.983

3.  Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial.

Authors:  S Connolly; J Pogue; R Hart; M Pfeffer; S Hohnloser; S Chrolavicius; M Pfeffer; S Hohnloser; S Yusuf
Journal:  Lancet       Date:  2006-06-10       Impact factor: 79.321

4.  Safety and efficacy of combined antiplatelet-warfarin therapy after coronary stenting.

Authors:  Pasi P Karjalainen; Pekka Porela; Antti Ylitalo; Saila Vikman; Kai Nyman; Mari-Anne Vaittinen; Tuukka J Airaksinen; Matti Niemelä; Tero Vahlberg; K E Juhani Airaksinen
Journal:  Eur Heart J       Date:  2007-01-31       Impact factor: 29.983

5.  A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators.

Authors:  M B Leon; D S Baim; J J Popma; P C Gordon; D E Cutlip; K K Ho; A Giambartolomei; D J Diver; D M Lasorda; D O Williams; S J Pocock; R E Kuntz
Journal:  N Engl J Med       Date:  1998-12-03       Impact factor: 91.245

6.  A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents.

Authors:  A Schömig; F J Neumann; A Kastrati; H Schühlen; R Blasini; M Hadamitzky; H Walter; E M Zitzmann-Roth; G Richardt; E Alt; C Schmitt; K Ulm
Journal:  N Engl J Med       Date:  1996-04-25       Impact factor: 91.245

Review 7.  Triple therapy of warfarin, aspirin and a thienopyridine for patients treated with vitamin K antagonists undergoing coronary stenting. A review of the evidence.

Authors:  A Rubboli; G Di Pasquale
Journal:  Intern Emerg Med       Date:  2007-10-01       Impact factor: 3.397

8.  Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology.

Authors:  Sigmund Silber; Per Albertsson; Francisco F Avilés; Paolo G Camici; Antonio Colombo; Christian Hamm; Erik Jørgensen; Jean Marco; Jan-Erik Nordrehaug; Witold Ruzyllo; Philip Urban; Gregg W Stone; William Wijns
Journal:  Eur Heart J       Date:  2005-03-15       Impact factor: 29.983
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.